Nanotoxicology—A Pathologist’s Perspective

Toxicologic Pathology

Volumn 39, Issue 2, 2011, Pages 301-324

  Hubbs, Ann F ^a   Mercer, Robert R ^a   Benkovic, Stanley A ^a   Harkema, Jack ^b   Sriram, Krishnan ^a   Schwegler Berry, Diane ^a   Goravanahally, Madhusudan P ^a   Nurkiewicz, Timothy R ^c   Castranova, Vincent ^a   Sargent, Linda M ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

nano; nanopathology; nanotechnology; nanotoxicology; particulates; pathology; toxicology

Indexed keywords

CELL DNA; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; METAL NANOPARTICLE; NANOPARTICLE; SINGLE WALLED NANOTUBE;

ALLERGIC REACTION; CARCINOGENICITY; CARDIOVASCULAR EFFECT; CELL STRUCTURE; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CHEMICAL LABELING; DISSOLUTION; ENVIRONMENTAL EXPOSURE; FIBROSIS; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; HYBRIDIZATION; INFLAMMATION; INTRACELLULAR TRANSPORT; LEUKOCYTE ACTIVATION; MICROTUBULE; MITOSIS SPINDLE; MOLECULAR INTERACTION; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; TISSUE SECTION;

ANIMALS; CARCINOGENS; COSMETICS; DUST; ENVIRONMENTAL EXPOSURE; FIBROSIS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MUTAGENS; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE;

EID: 79954511842     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310390705     Document Type: Review

References (246)

1. Abbey D. E. Nishino N. McDonnell W. F. Burchette R. J. Knutsen S. F. Lawrence Beeson W. Yang J. X. (1999). Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 159, 373–82.
2. Abbracchio M. P. Simmons-Hansen J. Costa M. (1982). Cytoplasmic dissolution of phagocytized crystalline nickel sulfide particles: a prerequisite for nuclear uptake of nickel. J Toxicol Environ Health 9, 663–76.
3. Adams G. B. Sankey O. F. Page J. B. O’Keeffe M. Drabold D. A. (1992). Energetics of large fullerenes: balls, tubes, and capsules. Science 256, 1792–5.
4. Aitken R. J. Chaudhry M. Q. Boxall A. B. Hull M. (2006). Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med (Lond) 56, 300–6.
5. Ajayan P. M. Charlier J. Rinzler A. G. (1999). Carbon nanotubes: from macromolecules to nanotechnology. Proc Natl Acad Sci U S A 96, 14199–200.
6. Alessandrini F. Schulz H. Takenaka S. Lentner B. Karg E. Behrendt H. Jakob T. (2006). Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J Allergy Clin Immunol 117, 824–30.
7. Baan R. A. (2007). Carcinogenic hazards from inhaled carbon black, titanium dioxide, and talc not containing asbestos or asbestiform fibers: recent evaluations by an IARC Monographs Working Group. Inhal Toxicol 19 (Suppl. 1), 213–28.
8. Baggs R. B. Ferin J. Oberdörster G. (1997). Regression of pulmonary lesions produced by inhaled titanium dioxide in rats. Vet Pathol 34, 592–7.
9. Bang J. J. Guerrero P. A. Lopez D. A. Murr L. E. Esquivel E. V. (2004). Carbon nanotubes and other fullerene nanocrystals in domestic propane and natural gas combustion streams. J Nanosci Nanotechnol 4, 716–8.
10. Beck E. G. Holt P. F. Manojlovic N. (1972). Comparison of effects on macrophage cultures of glass fibre, glass powder, and chrysotile asbestos. Br J Ind Med 29, 280–6.
11. Bennat C. Muller-Goymann C. C. (2000). Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter. Int J Cosmet Sci 22, 271–83.
12. Bermudez E. Mangum J. B. Asgharian B. Wong B. A. Reverdy E. E. Janszen D. B. Hext P. M. Warheit D. B. Everitt J. I. (2002). Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 70, 86–97.
13. Bermudez E. Mangum J. B. Wong B. A. Asgharian B. Hext P. M. Warheit D. B. Everitt J. I. (2004). Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77, 347–57.
14. BeruBe K. Balharry D. Sexton K. Koshy L. Jones T. (2007). Combustion-derived nanoparticles: mechanisms of pulmonary toxicity. Clin Exp Pharmacol Physiol 34, 1044–50.
15. Bethune D. S. Klang C. H. de Vries M. S. Gorman G. Savoy R. Vazquez J. Beyers R. (1993). Cobalt-catalysed growth of carbon nanotubes with single-atomic-layer walls. Nature 363, 605–7.
16. Bhattacharyya M. Bradley H. (2006). Management of a difficult-to-heal chronic wound infected with methycillin-resistant staphylococcus aureus in a patient with psoriasis following a complex knee surgery. Int J Low Extrem Wounds 5, 105–8.
17. Bhattacharyya M. Bradley H. (2008). A case report of the use of nanocrystalline silver dressing in the management of acute surgical site wound infected with MRSA to prevent cutaneous necrosis following revision surgery. Int J Low Extrem Wounds 7, 45–8.
18. Bonner J. C. (2007). Lung fibrotic responses to particle exposure. Toxicol Pathol 35, 148–53.
19. Bonner J. C. (2010). Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc Am Thorac Soc 7, 138–41.
20. Boverhof D. R. David R. M. (2010). Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation. Anal Bioanal Chem 396, 953–61.
21. Bradley J. Nordan M. M. Tassinari O. (2009). The Recession’s Ripple Effect on Nanotech. Lux Research, Inc., Boston, MA.
22. Brown D. M. Wilson M. R. MacNee W. Stone V. Donaldson K. (2001). Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175, 191–9.
23. Calderón-Garcidueñas L. Gambling T. M. Acuna H. Garcia R. Osnaya N. Monroy S. Villarreal-Calderon A. Carson J. Koren H. S. Devlin R. B. (2001). Canines as sentinel species for assessing chronic exposures to air pollutants: part 2. Cardiac pathology. Toxicol Sci 61, 356–67.
24. Calderón-Garcidueñas L. Solt A. C. Henriquez-Roldan C. Torres-Jardon R. Nuse B. Herritt L. Villarreal-Calderon R. Osnaya N. Stone I. Garcia R. Brooks D. M. Gonzalez-Maciel A. Reynoso-Robles R. Delgado-Chavez R. Reed W. (2008). Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol Pathol 36, 289–310.
25. Cao X. Wang N. Wang L. (2010). Ultrathin ZnO nanorods: facile synthesis, characterization and optical properties. Nanotechnology 21, 065603.
26. Cassee F. R. Muijser H. Duistermaat E. Freijer J. J. Geerse K. B. Marijnissen J. C. Arts J. H. (2002). Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol 76, 277–86.
27. Cheng C. Muller K. H. Koziol K. K. Skepper J. N. Midgley P. A. Welland M. E. Porter A. E. (2009). Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells. Biomaterials 30, 4152–60.
28. Churg A. (1988). Chrysotile, tremolite, and malignant mesothelioma in man. Chest 93, 621–8.
29. Cirstoiu-Hapca A. Buchegger F. Bossy L. Kosinski M. Gurny R. Delie F. (2009). Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells. Eur J Pharm Sci 38, 230–7.
30. Cirstoiu-Hapca A. Buchegger F. Lange N. Bossy L. Gurny R. Delie F. (2010). Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. J Control Release. 144, 324–31.
31. Cohen M. D. Sisco M. Prophete C. Chen L. C. Zelikoff J. T. Ghio A. J. Stonehuerner J. D. Smee J. J. Holder A. A. Crans D. C. (2007). Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: vanadium agents. J Immunotoxicol 4, 49–60.
32. Cormode D. P. Skajaa T. Fayad Z. A. Mulder W. J. (2009). Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol 29, 992–1000.
33. Costa M. Davidson T. L. Chen H. Ke Q. Zhang P. Yan Y. Huang C. Kluz T. (2005). Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res 592, 79–88.
34. Curl R. F. Smalley R. E. (1988). Probing C60. Science 242, 1017–22.
35. Dankovic D. Kuempel E. Wheeler M. (2007). An approach to risk assessment for TiO2. Inhal Toxicol 19 (Suppl. 1), 205–12.
36. De Jong W. H. Borm P. J. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3, 133–49.
37. De Jong W. H. Hagens W. I. Krystek P. Burger M. C. Sips A. J. Geertsma R. E. (2008). Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912–9.
38. Devika M. Reddy N. K. Pevzner A. Patolsky F. (2010). Heteroepitaxial Si/ZnO hierarchical nanostructures for future optoelectronic devices. Chemphyschem 11, 809–14.
39. Diaz J. A. Cagin T. (2010). Thermo-mechanical stability and strength of peptide nanostructures from molecular dynamics: self-assembled cyclic peptide nanotubes. Nanotechnology 21, 115703.
40. Dinu C. Z. Bale S. S. Zhu G. Y. Dordick J. S. (2009). Tubulin encapsulation of carbon nanotubes into functional hybrid assemblies. Small 5, 310–5.
41. Doak S. H. Griffiths S. M. Manshian B. Singh N. Williams P. M. Brown A. P. Jenkins G. J. (2009). Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24, 285–93.
42. Dockery D. W. Pope C. A. III Xu X. Spengler J. D. Ware J. H. Fay M. E. Ferris B. G. Jr. Speizer F. E. (1993). An association between air pollution and mortality in six U.S. cities. N Engl J Med 329, 1753–9.
43. Donaldson K. Aitken R. Tran L. Stone V. Duffin R. Forrest G. Alexander A. (2006). Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 92, 5–22.
44. Donaldson K. Beswick P. H. Gilmour P. S. (1996). Free radical activity associated with the surface of particles: a unifying factor in determining biological activity? Toxicol Lett 88, 293–8.
45. Donaldson K. Brown D. Clouter A. Duffin R. MacNee W. Renwick L. Tran L. Stone V. (2002). The pulmonary toxicology of ultrafine particles. J Aerosol Med 15, 213–20.
46. Donaldson K. Murphy F. A. Duffin R. Poland C. A. (2010). Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 7, 5.
47. Duffin R. Mills N. L. Donaldson K. (2007). Nanoparticles—a thoracic toxicology perspective. Yonsei Med J 48, 561–72.
48. Ebbesen T. W. Ajayan P. M. (1992). Large-scale synthesis of carbon nanotubes. Nature 358, 220–2.
49. Elder A. Gelein R. Silva V. Feikert T. Opanashuk L. Carter J. Potter R. Maynard A. Ito Y. Finkelstein J. Oberdörster G. (2006). Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114, 1172–8.
50. Elgrabli D. Abella-Gallart S. Robidel F. Rogerieux F. Boczkowski J. Lacroix G. (2008). Induction of apoptosis and absence of inflammation in rat lung after intratracheal instillation of multiwalled carbon nanotubes. Toxicology 253, 131–6.
51. Erdely A. Hulderman T. Salmen R. Liston A. Zeidler-Erdely P. C. Schwegler-Berry D. Castranova V. Koyama S. Kim Y. A. Endo M. Simeonova P. P. (2009). Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett 9, 36–43.
52. Falta M. T. Bowerman N. A. Dai S. Kappler J. W. Fontenot A. P. (2010). Linking genetic susceptibility and T cell activation in beryllium-induced disease. Proc Am Thorac Soc 7, 126–9.
53. Finch G. L. Nikula K. J. Hoover M. D. (1998). Dose-response relationships between inhaled beryllium metal and lung toxicity in C3H mice. Toxicol Sci 42, 36–48.
54. Fischer H. C. Chan W. C. (2007). Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18, 565–71.
55. Fontenot A. P. Amicosante M. (2008). Metal-induced diffuse lung disease. Semin Respir Crit Care Med 29, 662–9.
56. Freiman D. G. Hardy H. L. (1970). Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. Beryllium Case Registry. Hum Pathol 1, 25–44.
57. Gaiser B. K. Fernandes T. F. Jepson M. Lead J. R. Tyler C. R. Stone V. (2009). Assessing exposure, uptake and toxicity of silver and cerium dioxide nanoparticles from contaminated environments. Environ Health 8 (Suppl. 1), S2.
58. Gatti A. M. Tossini D. Gambarelli A. Montanari S. Capitani F. (2009). Investigation of the presence of inorganic micro- and nanosized contaminants in bread and biscuits by environmental scanning electron microscopy. Crit Rev Food Sci Nutr 49, 275–82.
59. Gonzalez O. Smith R. L. Goodman S. B. (1996). Effect of size, concentration, surface area, and volume of polymethylmethacrylate particles on human macrophages in vitro. J Biomed Mater Res 30, 463–73.
60. Gopee N. V. Roberts D. W. Webb P. Cozart C. R. Siitonen P. H. Latendresse J. R. Warbitton A. R. Yu W. W. Colvin V. L. Walker N. J. Howard P. C. (2009). Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin. Toxicol Sci 111, 37–48.
61. Haas A. Fischer M. S. (1997). Three-dimensional reconstruction of histological sections using modern product-design software. Anat Rec 249, 510–6.
62. Han J. H. Lee E. J. Lee J. H. So K. P. Lee Y. H. Bae G. N. Lee S. B. Ji J. H. Cho M. H. Yu I. J. (2008). Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal Toxicol 20, 741–9.
63. Harmsen A. G. Mason M. J. Muggenburg B. A. Gillett N. A. Jarpe M. A. Bice D. E. (1987). Migration of neutrophils from lung to tracheobronchial lymph node. J Leukoc Biol 41, 95–103.
64. Harmsen A. G. Muggenburg B. A. Snipes M. B. Bice D. E. (1985). The role of macrophages in particle translocation from lungs to lymph nodes. Science 230, 1277–80.
65. Hoet P. Legiest B. Geys J. Nemery B. (2009). Do nanomedicines require novel safety assessments to ensure their safety for long-term human use? Drug Saf 32, 625–36.
66. Hubbs A. Greskevitch M. Kuempel E. Suarez F. Toraason M. (2005). Abrasive blasting agents: designing studies to evaluate relative risk. J Toxicol Environ Health A 68, 999–1016.
67. Hubbs A. F. Mercer R. R. Coad J. E. Battelli L. A. Willard P. Sriram K. Wolfarth M. Castranova V. Porter D. (2009). Persistent pulmonary inflammation, airway mucous metaplasia and migration of multi-walled carbon nanotubes from the lung after subchronic exposure. Toxicol Sci 108, 457.
68. Hubbs A. F. Mercer R. R. Sriram K. Castranova V. Chen B. T. McKinney W. Frazer D. G. Battelli L. A. Willard P. Scabilloni J. Schwegler-Berry D. Porter D. (2008). Acute respiratory toxicologic pathology of inhled multi-walled carbon nanotubes. Vet Pathol 45, 786.
69. Hunter D. D. Dey R. D. (1998). Identification and neuropeptide content of trigeminal neurons innervating the rat nasal epithelium. Neuroscience 83, 591–9.
70. Hunter D. D. Satterfield B. E. Huang J. Fedan J. S. Dey R. D. (2000). Toluene diisocyanate enhances substance P in sensory neurons innervating the nasal mucosa. Am J Respir Crit Care Med 161, 543–9.
71. Hunter D. D. Undem B. J. (1999). Identification and substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. Am J Respir Crit Care Med 159, 1943–8.
72. Iijima S. (1991). Helical microtubules of graphitic carbon. Nature 354, 56–8.
73. Iijima S. Ichihashi T. (1993). Single-shell carbon nanotubes of 1-nm diameter. Nature 363, 603–5.
74. ISO (2008). Nanotechnologies—Terminology and Definitions for Nano-Objects—Nanoparticle, Nanofibre and Nanoplate, ISO/TS 27687, p. 7. The International Organization for Standardization, Geneva, Switzerland.
75. Jaurand M. C. Renier A. Daubriac J. (2009). Mesothelioma: do asbestos and carbon nanotubes pose the same health risk? Part Fibre Toxicol 6, 16.
76. Jensen C. G. Watson M. (1999). Inhibition of cytokinesis by asbestos and synthetic fibres. Cell Biol Int 23, 829–40.
77. Ji J. H. Jung J. H. Kim S. S. Yoon J. U. Park J. D. Choi B. S. Chung Y. H. Kwon I. H. Jeong J. Han B. S. Shin J. H. Sung J. H. Song K. S. Yu I. J. (2007). Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 19, 857–71.
78. Jin H. Heller D. A. Sharma R. Strano M. S. (2009). Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 3, 149–58.
79. Johnson D. R. Methner M. M. Kennedy A. J. Steevens J. A. (2010). Potential for occupational exposure to engineered carbon-based nanomaterials in environmental laboratory studies. Environ Health Perspect 118, 49–54.
80. Johnson L. A. Clasper S. Holt A. P. Lalor P. F. Baban D. Jackson D. G. (2006). An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 203, 2763–77.
81. Johnson L. A. Jackson D. G. (2008). Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci 1131, 119–33.
82. Johnston H. J. Hutchison G. Christensen F. M. Peters S. Hankin S. Stone V. (2010). A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40, 328–46.
83. Kalishwaralal K. Banumathi E. Ram Kumar Pandian S. Deepak V. Muniyandi J. Eom S. H. Gurunathan S. (2009). Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerfaces 73, 51–7.
84. Kamp D. W. Graceffa P. Pryor W. A. Weitzman S. A. (1992). The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 12, 293–315.
85. Kateb B. Chiu K. Black K. L. Yamamoto V. Khalsa B. Ljubimova J. Y. Ding H. Patil R. Portilla-Arias J. A. Modo M. Moore D. F. Farahani K. Okun M. S. Prakash N. Neman J. Ahdoot D. Grundfest W. Nikzad S. Heiss J. D. (forthcoming). Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage, doi:10.1016/j.neuroimage.2010.01.105.
86. Kim J. S. Yoon T. J. Yu K. N. Kim B. G. Park S. J. Kim H. W. Lee K. H. Park S. B. Lee J. K. Cho M. H. (2006). Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 89, 338–47.
87. Kim W. Y. Choi Y. C. Min S. K. Cho Y. Kim K. S. (2009). Application of quantum chemistry to nanotechnology: electron and spin transport in molecular devices. Chem Soc Rev 38, 2319–33.
88. Kim W. Y. Kim J. Park J. D. Ryu H. Y. Yu I. J. (2009). Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J Toxicol Environ Health A 72, 1279–84.
89. Kim Y. S. Kim J. S. Cho H. S. Rha D. S. Kim J. M. Park J. D. Choi B. S. Lim R. Chang H. K. Chung Y. H. Kwon I. H. Jeong J. Han B. S. Yu I. J. (2008). Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20, 575–83.
90. Kisin E. R. Murray A. R. Keane M. J. Shi X. C. Schwegler-Berry D. Gorelik O. Arepalli S. Castranova V. Wallace W. E. Kagan V. E. Shvedova A. A. (2007). Single-walled carbon nanotubes: Geno- and cytotoxic effects in lung fibroblast V79 cells. Journal of Toxicology and Environmental Health—Part A—Current Issues 70, 2071–9.
91. Konduru N. V. Tyurina Y. Y. Feng W. Basova L. V. Belikova N. A. Bayir H. Clark K. Rubin M. Stolz D. Vallhov H. Scheynius A. Witasp E. Fadeel B. Kichambare P. D. Star A. Kisin E. R. Murray A. R. Shvedova A. A. Kagan V. E. (2009). Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS One 4, e4398
92. Koppinen P. J. Lievonen J. T. Ahlskog M. Maasilta I. J. (2010). Strain sensing with submicron Al-AlO(x)-Al tunnel junctions. Rev Sci Instrum 81, 023901.
93. Kreyling W. G. Semmler M. Erbe F. Mayer P. Takenaka S. Schulz H. Oberdörster G. Ziesenis A. (2002). Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. Journal of Toxicology and Environmental Health, Part A 65, 1513–30.
94. Kroto H. (1988). Space, stars, C60, and soot. Science 242, 1139–45.
95. Kroto H. W. Heath J. R. O’Brien S. C. Curl R. F. Smalley R. E. (1985). C60: buckminsterfullerene. Nature 318, 162–3.
96. Kwon J. T. Hwang S. K. Jin H. Kim D. S. Minai-Tehrani A. Yoon H. J. Choi M. Yoon T. J. Han D. Y. Kang Y. W. Yoon B. I. Lee J. K. Cho M. H. (2008). Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 50, 1–6.
97. Lam C. W. James J. T. McCluskey R. Arepalli S. Hunter R. L. (2006). A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36, 189–217.
98. Lam C. W. James J. T. McCluskey R. Hunter R. L. (2004). Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77, 126–34.
99. Landsiedel R. Kapp M. D. Schulz M. Wiench K. Oesch F. (2009). Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations—many questions, some answers. Mutat Res 681, 241–58.
100. Larsen S. T. Roursgaard M. Jensen K. A. Nielsen G. D. (2010). Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin Pharmacol Toxicol 106, 114–7.
101. Lasagna-Reeves C. Gonzalez-Romero D. Barria M. A. Olmedo I. Clos A. Sadagopa Ramanujam V. M. Urayama A. Vergara L. Kogan M. J. Soto C. (2010). Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393, 649–55.
102. LeBlanc A. J. Cumpston J. L. Chen B. T. Frazer D. Castranova V. Nurkiewicz T. R. (2009). Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J Toxicol Environ Health A 72, 1576–84.
103. LeBlanc A. J. Moseley A. M. Chen B. T. Frazer D. Castranova V. Nurkiewicz T. R. (2010). Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovasc Toxicol 10, 27–36.
104. Lee C. M. Jeong H. J. Cheong S. J. Kim E. M. Kim D. W. Lim S. T. Sohn M. H. (2010). Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin. Pharm Res 27, 712–21.
105. Li X. Peng Y. Qu X. (2006). Carbon nanotubes selective destabilization of duplex and triplex DNA and inducing B-A transition in solution. Nucleic Acids Res 34, 3670–6.
106. Li Z. Hulderman T. Salmen R. Chapman R. Leonard S. S. Young S. H. Shvedova A. Luster M. I. Simeonova P. P. (2007). Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect 115, 377–82.
107. Lindberg H. K. Falck G. C. Suhonen S. Vippola M. Vanhala E. Catalan J. Savolainen K. Norppa H. (2009). Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol Lett 186, 166–73.
108. Linkov I. Satterstrom F. K. Corey L. M. (2008). Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine 4, 167–71.
109. Lison D. Lardot C. Huaux F. Zanetti G. Fubini B. (1997). Influence of particle surface area on the toxicity of insoluble manganese dioxide dusts. Arch Toxicol 71, 725–9.
110. Lison D. Muller J. (2008). To the editor. Toxicol Sci 101, 179–80.
111. Lockman P. R. Koziara J. M. Mumper R. J. Allen D. D. (2004). Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12, 635–41.
112. Lomer M. C. Thompson R. P. Powell J. J. (2002). Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn’s disease. Proc Nutr Soc 61, 123–30.
113. Long C. Saleh N. Tilton R. D. Lowry G. V. Veronesi B. (2006). Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 40, 4346–52.
114. Lu J. P. (1997). Elastic properties of carbon nanotubes and nanoropes. Physical Review Letters 79, 1297–300.
115. Mangum J. B. Turpin E. A. Antao-Menezes A. Cesta M. F. Bermudez E. Bonner J. C. (2006). Single-walled carbon nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages in situ. Part Fibre Toxicol 3, 15.
116. Maynard A. D. Aitken R. J. (2007). Assessing exposure to airborne nanomaterials: current abilities and future requirements. Nanotoxicology 1, 26–41.
117. Maynard A. D. Baron P. A. Foley M. Shvedova A. A. Kisin E. R. Castranova V. (2004). Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 67, 87–107.
118. Maynard A. D. Kuempel E. D. (2005). Airborne nanostructured particles and occupational health. J Nanoparticle Res 7, 587–614.
119. McCleskey T. M. Buchner V. Field R. W. Scott B. L. (2009). Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. Rev Environ Health 24, 75–115.
120. McDonald J. Mitchell L. (2008). To the editor. Toxicol Sci 101, 181–2.
121. Mercer R. R. Hubbs A. F. Scabilloni J. F. Wang L. Castranova V. Porter D. (2010). Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Am J Respir Crit Care Med 181, A3102
122. Mercer R. R. Russell M. L. Crapo J. D. (1994). Alveolar septal structure in different species. J Appl Physiol 77, 1060–6.
123. Mercer R. R. Scabilloni J. Wang L. Kisin E. Murray A. R. Schwegler-Berry D. Shvedova A. A. Castranova V. (2008). Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol 294, L87–97.
124. Mercer R. R. Scabilloni J. F. Wang L. Battelli L. A. Castranova V. (2009). Use of labeled single wall carbon nanotubes to study translocation from the lungs. The Toxicologist 108, A2192.
125. Methner M. Hodson L. Dames A. Geraci C. (2010). Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials—Part B: results from 12 field studies. J Occup Environ Hyg 7, 163–76.
126. Methner M. Hodson L. Geraci C. (2010). Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials—Part A. J Occup Environ Hyg 7, 127–32.
127. Miller B. E. Dethloff L. A. Gladen B. C. Hook G. E. (1987). Progression of type II cell hypertrophy and hyperplasia during silica-induced pulmonary inflammation. Lab Invest 57, 546–54.
128. Miller B. E. Dethloff L. A. Hook G. E. (1986). Silica-induced hypertrophy of type II cells in the lungs of rats. Lab Invest 55, 153–63.
129. Miller B. E. Hook G. E. (1990). Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants. Environ Health Perspect 85, 15–23.
130. Mitchell L. A. Gao J. Wal R. V. Gigliotti A. Burchiel S. W. McDonald J. D. (2007). Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci 100, 203–14.
131. Monteiller C. Tran L. MacNee W. Faux S. Jones A. Miller B. Donaldson K. (2007). The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 64, 609–15.
132. Muhle H. Kittel B. Ernst H. Mohr U. Mermelstein R. (1995). Neoplastic lung lesions in rat after chronic exposure to crystalline silica. Scand J Work Environ Health 21 (Suppl. 2), 27–9.
133. Muller J. Decordier I. Hoet P. H. Lombaert N. Thomassen L. Huaux F. Lison D. Kirsch-Volders M. (2008). Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells. Carcinogenesis 29, 427–33.
134. Muller J. Delos M. Panin N. Rabolli V. Huaux F. Lison D. (2009). Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci 110, 442–8.
135. Muller J. Huaux F. o. Fonseca A. Nagy J. B. Moreau N. Delos M. Raymundo-Pinifero E. Beilguin F. O. Kirsch-Volders M. Fenoglio I. Fubini B. Lison D. (2008). Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chemical Research in Toxicology 21, 1698–705.
136. Muller J. Huaux F. Moreau N. Misson P. Heilier J. F. Delos M. Arras M. Fonseca A. Nagy J. B. Lison D. (2005). Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 207, 221–31.
137. Murai Y. Kitagawa M. Matsui K. Koizumi F. Miwa A. (1995). Asbestos fiber analysis in nine lung cancer cases with high asbestos exposure. Arch Environ Health 50, 320–5.
138. Murashov V. (2009). Occupational exposure to nanomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1, 203–13.
139. Murashov V. Engel S. Savolainen K. Fullam B. Lee M. Kearns P. (2009). Occupational safety and health in nanotechnology and Organisation for Economic Cooperation and Development. J Nanopart Res 11, 1587–91.
140. Murr L. E. (2008). Microstructures and nanostructures for environmental carbon nanotubes and nanoparticulate soots. Int J Environ Res Public Health 5, 321–36.
141. National Research Council (2006). A matter of size: triennial review of the National Nanotechnology Initiative. National Academies Press, Washington, DC.
142. A., Nemmar, P.P.M., Hoet, B., Vanquickenborne, D., Dinsdale, M., Thomeer, M.F., Hoylaerts, H., Vanbilloen, L., Mortelmans, B., Nemery, Passage of inhaled particles into the blood circulation in humans, Circulation, (2002), 105, 411-414
143. Nemmar A. Vanbilloen H. Hoylaerts M. F. Hoet P. H. Verbruggen A. Nemery B. (2001). Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med 164, 1665–8.
144. Nestle F. O. Di Meglio P. Qin J. Z. Nickoloff B. J. (2009). Skin immune sentinels in health and disease. Nat Rev Immunol 9, 679–91.
145. Nielsen G. D. Roursgaard M. Jensen K. A. Poulsen S. S. Larsen S. T. (2008). In vivo biology and toxicology of fullerenes and their derivatives. Basic Clin Pharmacol Toxicol 103, 197–208.
146. Niidome Y. Nishioka K. Kawasaki H. Yamada S. (2003). Rapid synthesis of gold nanorods by the combination of chemical reduction and photoirradiation processes; morphological changes depending on the growing processes. Chem Commun (Camb), 2376–7.
147. Nikula K. J. (2000). Rat lung tumors induced by exposure to selected poorly soluble nonfibrous particles. Inhal Toxicol 12, 97–119.
148. Nikula K. J. Swafford D. S. Hoover M. D. Tohulka M. D. Finch G. L. (1997). Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice. Toxicol Pathol 25, 2–12.
149. NIOSH (2009). Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated with Engineered Nanomaterials, pp. 1–104. Department of Health and Human Services, Washington, DC.
150. Nohynek G. J. Antignac E. Re T. Toutain H. (2010). Safety assessment of personal care products/cosmetics and their ingredients. Toxicol Appl Pharmacol 243, 239–59.
151. Nurkiewicz T. R. Donlin M. Hubbs A. Goodwill A. Frisbee J. Chen B. Frazer D. Castranova V. (2009). Mechanistic links between the lung and the systemic microcirculation after nanoparticle exposure. The Toxicologist 108, A1353.
152. Nurkiewicz T. R. Porter D. W. Barger M. Millecchia L. Rao K. M. Marvar P. J. Hubbs A. F. Castranova V. Boegehold M. A. (2006). Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ Health Perspect 114, 412–9.
153. Nurkiewicz T. R. Porter D. W. Hubbs A. F. Cumpston J. L. Chen B. T. Frazer D. G. Castranova V. (2008). Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre Toxicol 5, 1.
154. Oberdörster G. (1996). Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal Toxicol 8 (Suppl.), 73–89.
155. Oberdörster G. (2002). Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol 14, 29–56.
156. Oberdörster G. (2010). Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267, 89–105.
157. Oberdörster G. Ferin J. Lehnert B. E. (1994). Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102 (Suppl. 5), 173–9.
158. Oberdörster G. Finkelstein J. N. Johnston C. Gelein R. Cox C. Baggs R. Elder A. C. (2000). Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst, 5–74; discussion 75–86.
159. Oberdörster G. Maynard A. Donaldson K. Castranova V. Fitzpatrick J. Ausman K. Carter J. Karn B. Kreyling W. Lai D. Olin S. Monteiro-Riviere N. Warheit D. Yang H. (2005). Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2, 8.
160. Oberdörster G. Oberdörster E. Oberdörster J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113, 823–39.
161. Oberdörster G. Sharp Z. Atudorei V. Elder A. Gelein R. Kreyling W. Cox C. (2004). Translocation of inhaled ultrafine particles to the brain. Inhalation Toxicology 16, 437–45.
162. Oberdörster G. Sharp Z. Atudorei V. Elder A. Gelein R. Lunts A. Kreyling W. Cox C. (2002). Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 65, 1531–43.
163. Oberdörster G. Stone V. Donaldson K. (2007). Toxicology of nanoparticles: A historical perspective. Nanotoxicology 1, 2–25.
164. OSHA (2006). 29 CFR—Occupational Safety and Health Regulations (OSHA Standards). In Toxic and Hazardous Substances, Vol. Standards—29 CFR. Occupational Safety and Health Administration, Washington, DC. http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=9992
165. Pacurari M. Castranova V. Vallyathan V. (2010). Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans? J Toxicol Environ Health A 73, 378–95.
166. Pampaloni F. Florin E. L. (2008). Microtubule architecture: inspiration for novel carbon nanotube-based biomimetic materials. Trends Biotechnol 26, 302–10.
167. Park E. J. Yi J. Kim Y. Choi K. Park K. (2010). Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24, 872–8.
168. Partha R. Conyers J. L. (2009). Biomedical applications of functionalized fullerene-based nanomaterials. Int J Nanomedicine 4, 261–75.
169. Paulose M. Varghese O. K. Grimes C. A. (2003). Synthesis of gold-silica composite nanowires through solid-liquid-solid phase growth. J Nanosci Nanotechnol 3, 341–6.
170. Pauluhn J. (2010). Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol Sci 113, 226–42.
171. Pope C. A. III Thun M. J. Namboodiri M. M. Dockery D. W. Evans J. S. Speizer F. E. Heath C. W. Jr. (1995). Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 151, 669–74.
172. Porter A. E. Gass M. Bendall J. S. Muller K. Goode A. Skepper J. N. Midgley P. A. Welland M. (2009). Uptake of noncytotoxic acid-treated single-walled carbon nanotubes into the cytoplasm of human macrophage cells. ACS Nano 3, 1485–92.
173. Porter A. E. Gass M. Muller K. Skepper J. N. Midgley P. A. Welland M. (2007). Direct imaging of single-walled carbon nanotubes in cells. Nat Nanotechnol 2, 713–7.
174. Porter D. W. Holian A. Sriram K. Wu N. Wolfarth M. Hamilton R. F. Buford M. (2008). Engineered titanium dioxide nanowire toxicity in vitro and in vivo (abstract). The Toxicologist 102, A1492.
175. Porter D. W. Hubbs A. F. Baron P. A. Millecchia L. L. Wolfarth M. G. Battelli L. A. Schwegler-Berry D. E. Beighley C. M. Andrew M. E. Castranova V. (2007). Pulmonary toxicity of Expancel microspheres in the rat. Toxicol Pathol 35, 702–14.
176. Porter D. W. Hubbs A. F. Mercer R. Robinson V. A. Ramsey D. McLaurin J. Khan A. Battelli L. Brumbaugh K. Teass A. Castranova V. (2004). Progression of lung inflammation and damage in rats after cessation of silica inhalation. Toxicol Sci 79, 370–80.
177. Porter D. W. Hubbs A. F. Mercer R. R. Wu N. Wolfarth M. G. Sriram K. Leonard S. Battelli L. Schwegler-Berry D. Friend S. Andrew M. Chen B. T. Tsuruoka S. Endo M. Castranova V. (2010). Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 269, 136–47.
178. Porter D. W. Ramsey D. Hubbs A. F. Battelli L. Ma J. Barger M. Landsittel D. Robinson V. A. McLaurin J. Khan A. Jones W. Teass A. Castranova V. (2001). Time course of pulmonary response of rats to inhalation of crystalline silica: histological results and biochemical indices of damage, lipidosis, and fibrosis. J Environ Pathol Toxicol Oncol 20 (Suppl. 1), 1–14.
179. Porter D. W. Wolfarth M. G. Chen B. T. McKinney W. Hubbs A. F. Battelli L. Andrew A. Frazier D. G. Castranova V. (2009). Pulmonary toxicity of inhaled multi-walled carbon nanotubes. The Toxicologist 108, 457
180. Poteracki J. Walsh K. M. (1998). Spontaneous neoplasms in control Wistar rats: a comparison of reviews. Toxicol Sci 45, 1–8.
181. Powers C. M. Wrench N. Ryde I. T. Smith A. M. Seidler F. J. Slotkin T. A. (2010). Silver impairs neurodevelopment: studies in PC12 cells. Environ Health Perspect 118, 73–9.
182. Rahman M. F. Wang J. Patterson T. A. Saini U. T. Robinson B. L. Newport G. D. Murdock R. C. Schlager J. J. Hussain S. M. Ali S. F. (2009). Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 187, 15–21.
183. Renwick L. C. Brown D. Clouter A. Donaldson K. (2004). Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 61, 442–7.
184. Roberts J. R. Schwegler-Berry D. Chapman R. Antonini J. M. Scabilloni J. F. Castranova V. Mercer R. R. (2009). Biodistribution of quantum dots after pulmonary exposure in rats. The Toxicologist 108, A240.
185. Roller M. (2009). Carcinogenicity of inhaled nanoparticles. Inhal Toxicol 21 (Suppl. 1), 144–57.
186. Rosas-Hernandez H. Jimenez-Badillo S. Martinez-Cuevas P. P. Gracia-Espino E. Terrones H. Terrones M. Hussain S. M. Ali S. F. Gonzalez C. (2009). Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett 191, 305–13.
187. Ryman-Rasmussen J. P. Cesta M. F. Brody A. R. Shipley-Phillips J. K. Everitt J. I. Tewksbury E. W. Moss O. R. Wong B. A. Dodd D. E. Andersen M. E. Bonner J. C. (2009). Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 4, 747–51.
188. Sadrieh N. Wokovich A. M. Gopee N. V. Zheng J. Haines D. Parmiter D. Siitonen P. H. Cozart C. R. Patri A. K. McNeil S. E. Howard P. C. Doub W. H. Buhse L. F. (2010). Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles. Toxicol Sci 115, 156–66.
189. Sager T. M. Castranova V. (2009). Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre Toxicol 6, 15.
190. Sager T. M. Kommineni C. Castranova V. (2008). Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol 5, 17.
191. Sager T. M. Porter D. W. Robinson V. A. Lindsley W. G. Schwegler-Berry D. E. Castranova V. (2007). Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 1, 118–29.
192. Sakamoto Y. Nakae D. Fukumori N. Tayama K. Maekawa A. Imai K. Hirose A. Nishimura T. Ohashi N. Ogata A. (2009). Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J Toxicol Sci 34, 65–76.
193. Samet J. M. Dominici F. Curriero F. C. Coursac I. Zeger S. L. (2000). Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 343, 1742–9.
194. Sargent L. M. Shvedova A. A. Hubbs A. F. Salisbury J. L. Benkovic S. A. Kashon M. L. Lowry D. T. Murray A. R. Kisin E. R. Friend S. McKinstry K. T. Battelli L. Reynolds S. H. (2009). Induction of aneuploidy by single-walled carbon nanotubes. Environ Mol Mutagen 50, 708–17.
195. Sayes C. M. Warheit D. B. (2009). Characterization of nanomaterials for toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1, 660–70.
196. SCENIHR, S. C. o. E. a. N. I. H. R. E. (29 November 2007). The Scientific Aspects of the Existing and Proposed Definitions Relating to Products of Nanoscience and Nanotechnologies, p. 22. European Commission, Health & Consumer Protection DG, Brussels.
197. Schmid O. Moller W. Semmler-Behnke M. Ferron G. A. Karg E. Lipka J. Schulz H. Kreyling W. G. Stoeger T. (2009). Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers 14 (Suppl. 1), 67–73.
198. Sharma H. S. Hussain S. Schlager J. Ali S. F. Sharma A. (2010). Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir Suppl 106, 359–64.
199. Shimada A. Kawamura N. Okajima M. Kaewamatawong T. Inoue H. Morita T. (2006). Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol Pathol 34, 949–57.
200. Shvedova A. A. Kisin E. R. Mercer R. Murray A. R. Johnson V. J. Potapovich A. I. Tyurina Y. Y. Gorelik O. Arepalli S. Schwegler-Berry D. Hubbs A. F. Antonini J. Evans D. E. Ku B. K. Ramsey D. Maynard A. Kagan V. E. Castranova V. Baron P. (2005). Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289, L698–708.
201. Shvedova A. A. Kisin E. Murray A. R. Johnson V. J. Gorelik O. Arepalli S. Hubbs A. F. Mercer R. R. Keohavong P. Sussman N. Jin J. Yin J. Stone S. Chen B. T. Deye G. Maynard A. Castranova V. Baron P. A. Kagan V. E. (2008). Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 295, L552–65.
202. Sinnott S. (2002). Chemical functionalization of carbon nanotubes. J Nanosci Nanotech 2, 113–23.
203. Snyder J. A. Demchuk E. McCanlies E. C. Schuler C. R. Kreiss K. Andrew M. E. Frye B. L. Ensey J. S. Stanton M. L. Weston A. (2008). Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease. J R Soc Interface 5, 749–58.
204. Sonavane G. Tomoda K. Makino K. (2008). Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66, 274–80.
205. Sriram K. Porter D. W. Jefferson A. M. Lin G. X. Wolfarth M. G. Chen B. T. McKinney W. Frazer D. G. Castranova V. (2009). Neuroinflammation and blood-brain barrier changes following exposure to engineered nanomaterials (abstract). The Toxicologist 108, A2197.
206. Sriram K. Porter D. W. Tsuruoka S. Endo M. Jefferson A. M. Wolfarth M. G. Castranova V. Luster M. I. (2007). Neuroinflammatory responses following exposure to engineered nanomaterials (abstract). The Toxicologist 96, A288.
207. Stanton M. F. Layard M. Tegeris A. Miller E. May M. Morgan E. Smith A. (1981). Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 67, 965–75.
208. Stone V. Johnston H. Clift M. J. (2007). Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobioscience 6, 331–40.
209. Sung J. H. Ji J. H. Park J. D. Yoon J. U. Kim D. S. Jeon K. S. Song M. Y. Jeong J. Han B. S. Han J. H. Chung Y. H. Chang H. K. Lee J. H. Cho M. H. Kelman B. J. Yu I. J. (2009). Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108, 452–61.
210. Suzuki Y. Yuen S. R. Ashley R. (2005). Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health 208, 201–10.
211. Takagi A. Hirose A. Nishimura T. Fukumori N. Ogata A. Ohashi N. Kitajima S. Kanno J. (2008). Induction of mesothelioma in p53+/– mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33, 105–16.
212. Takenaka S. Karg E. Roth C. Schulz H. Ziesenis A. Heinzmann U. Schramel P. Heyder J. (2001). Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109 (Suppl. 4), 547–51.
213. Tang J. Xiong L. Wang S. Wang J. Liu L. Li J. Yuan F. Xi T. (2009). Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9, 4924–32.
214. Tarantino-Hutchison L. M. Sorrentino C. Nadas A. Zhu Y. Rubin E. M. Tinkle S. S. Weston A. Gordon T. (2009). Genetic determinants of sensitivity to beryllium in mice. J Immunotoxicol 6, 130–5.
215. R., Taylor, D.D.M., Walton, The chemistry of fullerenes, Nature, (1993), 363, 685-693
216. Tian Q. Zhang C. N. Wang X. H. Wang W. Huang W. Cha R. T. Wang C. H. Yuan Z. Liu M. Wan H. Y. Tang H. (2010). Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 31, 4748–56.
217. Tin Tin Win S. Yamamoto S. Ahmed S. Kakeyama M. Kobayashi T. Fujimaki H. (2006). Brain cytokine and chemokine mRNA expression in mice induced by intranasal instillation with ultrafine carbon black. Toxicol Lett 163, 153–60.
218. Tinkle S. S. Antonini J. M. Rich B. A. Roberts J. R. Salmen R. DePree K. Adkins E. J. (2003). Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111, 1202–8.
219. Tran C. L. Buchanan D. Cullen R. T. Searl A. Jones A. D. Donaldson K. (2000). Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. Inhal Toxicol 12, 1113–26.
220. Tsai S. J. Hofmann M. Hallock M. Ada E. Kong J. Ellenbecker M. (2009). Characterization and evaluation of nanoparticle release during the synthesis of single-walled and multiwalled carbon nanotubes by chemical vapor deposition. Environ Sci Technol 43, 6017–23.
221. Tsuji J. S. Maynard A. D. Howard P. C. James J. T. Lam C. W. Warheit D. B. Santamaria A. B. (2006). Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci 89, 42–50.
222. Vallyathan V. Castranova V. Pack D. Leonard S. Shumaker J. Hubbs A. F. Shoemaker D. A. Ramsey D. M. Pretty J. R. McLaurin J. L. (1995). Freshly fractured quartz inhalation leads to enhanced lung injury and inflammation. Potential role of free radicals. Am J Respir Crit Care Med 152, 1003–9.
223. Vallyathan V. Kang J. H. Van Dyke K. Dalal N. S. Castranova V. (1991). Response of alveolar macrophages to in vitro exposure to freshly fractured versus aged silica dust: the ability of Prosil 28, an organosilane material, to coat silica and reduce its biological reactivity. J Toxicol Environ Health 33, 303–15.
224. Vallyathan V. Shi X. L. Dalal N. S. Irr W. Castranova V. (1988). Generation of free radicals from freshly fractured silica dust. Potential role in acute silica-induced lung injury. Am Rev Respir Dis 138, 1213–9.
225. Varga C. Szendi K. (2010). Carbon nanotubes induce granulomas but not mesotheliomas. In Vivo 24, 153–6.
226. Veronesi B. Tajuba J. Saleh N. Ward W. Hester S. Carter J. Lowry G. V. (2008). Functionally charged polystyrene particles activate immortalized mouse microglia (BV2): cellular and genomic response. Nanotoxicology 2, 130–43.
227. Wallace W. E. Harrison J. Keane M. J. Bolsaitis P. Eppelsheimer D. Poston J. Page S. J. (1990). Clay occlusion of respirable quartz particles detected by low voltage scanning electron microscopy-X-ray analysis. Ann Occup Hyg 34, 195–204.
228. Wallace W. E. Jr. Vallyathan V. Keane M. J. Robinson V. (1985). In vitro biologic toxicity of native and surface-modified silica and kaolin. J Toxicol Environ Health 16, 415–24.
229. Walsh K. M. Poteracki J. (1994). Spontaneous neoplasms in control Wistar rats. Fundam Appl Toxicol 22, 65–72.
230. Wang F. Hwang Y. Qian P. Z. Wang X. (2010). A statistics-guided approach to precise characterization of nanowire morphology. ACS Nano 4, 855–62.
231. Wang J. Liu Y. Li Y. C. (2009). A new class of boron nanotube. Chemphyschem 10, 3119–21.
232. Wang J. Zhou G. Chen C. Yu H. Wang T. Ma Y. Jia G. Gao Y. Li B. Sun J. Li Y. Jiao F. Zhao Y. Chai Z. (2007). Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicology Letters 168, 176–85.
233. Wang L. Mercer R. R. Rojanasakul Y. Qiu A. Lu Y. Scabilloni J. F. Wu N. Castranova V. (2010). Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. J Toxicol Environ Health A 73, 410–22.
234. Warheit D. B. Laurence B. R. Reed K. L. Roach D. H. Reynolds G. A. Webb T. R. (2004). Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77, 117–25.
235. Warheit D. B. Reed K. L. Sayes C. M. (2009). A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhal Toxicol 21 (Suppl. 1), 61–7.
236. Watari F. Takashi N. Yokoyama A. Uo M. Akasaka T. Sato Y. Abe S. Totsuka Y. Tohji K. (2009). Material nanosizing effect on living organisms: non-specific, biointeractive, physical size effects. J R Soc Interface 6 (Suppl. 3), S371–88.
237. Wirtz M. Yu S. Martin C. R. (2002). Template synthesized gold nanotube membranes for chemical separations and sensing. Analyst 127, 871–9.
238. Wise S. S. Holmes A. L. Ketterer M. E. Hartsock W. J. Fomchenko E. Katsifis S. Thompson W. D. Wise J. P. Sr. (2004). Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells. Mutat Res 560, 79–89.
239. Wise S. S. Holmes A. L. Xie H. Thompson W. D. Wise J. P. Sr. (2006). Chronic exposure to particulate chromate induces spindle assembly checkpoint bypass in human lung cells. Chem Res Toxicol 19, 1492–8.
240. Wu J. Liu W. Xue C. Zhou S. Lan F. Bi L. Xu H. Yang X. Zeng F. D. (2009). Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett 191, 1–8.
241. Wu M. Gordon R. E. Herbert R. Padilla M. Moline J. Mendelson D. Litle V. Travis W. D. Gil J. (2010). Case report: lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samples. Environ Health Perspect 118, 499–504.
242. Wu Y. Zhou Q. Li H. Liu W. Wang T. Jiang G. (2010). Effects of silver nanoparticles on the development and histopathology biomarkers of Japanese medaka (Oryzias latipes) using the partial-life test. Aquat Toxicol. 100, 160–67.
243. Wu Z. X. Barker J. S. Batchelor T. P. Dey R. D. (2008). Interleukin (IL)-1 regulates ozone-enhanced tracheal smooth muscle responsiveness by increasing substance P (SP) production in intrinsic airway neurons of ferret. Respir Physiol Neurobiol 164, 300–11.
244. Yamago S. Tokuyama H. Nakamura E. Kikuchi K. Kananishi S. Sueki K. Nakahara H. Enomoto S. Ambe F. (1995). In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 2, 385–9.
245. Yegles M. Janson X. Dong H. Y. Renier A. Jaurand M. C. (1995). Role of fibre characteristics on cytotoxicity and induction of anaphase/telophase aberrations in rat pleural mesothelial cells in vitro: correlations with in vivo animal findings. Carcinogenesis 16, 2751–8.
246. Yu M. F. Lourie O. Dyer M. J. Moloni K. Kelly T. F. Ruoff R. S. (2000). Strength and breaking mechanism of multiwalled carbon nanotubes under tensile load. Science 287, 637–40.